Are Upfront Levels for Colon "Polyps" Necessary? A Pragmatic Review.

GI pathology cost saving initial levels polyps value

Journal

International journal of surgical pathology
ISSN: 1940-2465
Titre abrégé: Int J Surg Pathol
Pays: United States
ID NLM: 9314927

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 27 6 2018
medline: 14 6 2019
entrez: 27 6 2018
Statut: ppublish

Résumé

Colon biopsies are among the most frequently examined specimens by pathologists. Many pathology practices, ours included, review upfront levels on all gastrointestinal biopsies. In our experience, when a lesion is present on specimens labeled "colon polyp," it is readily identified on the first level. To test our hypothesis, we re-reviewed 500 cases in which a lesion was identified histologically and determined if the diagnosis could be made on the first level. Furthermore, we examined 50 additional cases of high-grade dysplasia/carcinoma to determine if the higher-grade component was also present on the first level. Cases were retrieved for lesions that could account for a colon polyp clinically, and the first level was examined to determine if lesional tissue was present on the first level. Fifty additional cases of higher-grade lesions were included to ensure higher-grade lesions were present on the first level. Overall, 497/500 (99.4%) of the non-high-grade lesions were present on the first level, whereas 3/500 (0.6%) required the additional level for diagnosis. All 50 high-grade lesions were present on the first level examined. Many pathology practices routinely order upfront levels on all gastrointestinal biopsies, often generating 2 or 3 slides. Additional slides increase costs, increase the likelihood of laboratory-generated errors, and can waste limited tissue on small biopsies for which ancillary studies may be necessary. Our study showed that a single level is sufficient in the overwhelming majority of cases in which a lesion is identified histologically.

Identifiants

pubmed: 29944023
doi: 10.1177/1066896918783264
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15-18

Auteurs

Armen Khararjian (A)

1 Johns Hopkins Hospital, Baltimore, MD, USA.

Rifat Mannan (R)

1 Johns Hopkins Hospital, Baltimore, MD, USA.

Kathleen Byrnes (K)

1 Johns Hopkins Hospital, Baltimore, MD, USA.

Norman Barker (N)

1 Johns Hopkins Hospital, Baltimore, MD, USA.

Lysandra Voltaggio (L)

1 Johns Hopkins Hospital, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH